Biocryst Pharmaceuticals Inc (BCRX)

Long-Term Debt

$406.85M

Quarterly · Period ending: · USD

BCRX logo

BCRX Long-Term Debt

Latest reported$406.85M
BCRX Quarterly Long-Term Debt ($800.00K → $406.85M)
High-resolution chart · PNG

BCRX long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
406,852,000
814,673,000
437,245,000
643,640,000
701,168,000
792,119,000
805,970,000
806,250,000
818,960,000
824,138,000
822,500,000
843,147,000
825,100,000
752,867,000
739,083,000
719,616,000
150,714,000
610,918,000
591,419,000
137,085,000
130,896,000
126,922,000
248,323,000
30,812,000
35,549,000
40,242,000
44,695,000
49,584,000
53,589,000
53,505,000
28,075,000
30,997,000
16,180,000
17,845,000
19,501,000
21,149,000
22,703,000
24,315,000
25,481,000
25,340,000
2,589,000
2,506,000
2,375,000
0
0
0
0
0
0
30,000,000
30,000,000
30,000,000
30,000,000
30,000,000
30,000,000
30,000,000
30,000,000
30,000,000
30,000,000
30,000,000
30,000,000
30,000,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.